193 related articles for article (PubMed ID: 34718471)
1. Inhibition of the BMP pathway prevents development of Barrett's-associated adenocarcinoma in a surgical rat model.
Westra WM; Straub D; Milano F; Buttar NS; Wang KK; Krishnadath KK
Dis Esophagus; 2022 May; 35(5):. PubMed ID: 34718471
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of esophageal cancer from reflux esophagitis].
Kawano T; Nakajima Y; Kawada K
Nihon Rinsho; 2016 Aug; 74(8):1393-1400. PubMed ID: 30562449
[TBL] [Abstract][Full Text] [Related]
3. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen.
Goldstein SR; Yang GY; Curtis SK; Reuhl KR; Liu BC; Mirvish SS; Newmark HL; Yang CS
Carcinogenesis; 1997 Nov; 18(11):2265-70. PubMed ID: 9395230
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
[TBL] [Abstract][Full Text] [Related]
5. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
Lee JS; Oh TY; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Kim HJ; Hahm KB
Mutat Res; 2001 Sep; 480-481():189-200. PubMed ID: 11506813
[TBL] [Abstract][Full Text] [Related]
6. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
Wang RH
World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
Kelly RJ; Ansari AM; Miyashita T; Zahurak M; Lay F; Ahmed AK; Born LJ; Pezhouh MK; Salimian KJ; Ng C; Matsangos AE; Stricker-Krongrad AH; Mukaisho KI; Marti GP; Chung CH; Canto MI; Rudek MA; Meltzer SJ; Harmon JW
Ann Surg; 2021 Jun; 273(6):e206-e213. PubMed ID: 31290765
[TBL] [Abstract][Full Text] [Related]
8. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
10. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.
Milano F; van Baal JW; Buttar NS; Rygiel AM; de Kort F; DeMars CJ; Rosmolen WD; Bergman JJ; VAn Marle J; Wang KK; Peppelenbosch MP; Krishnadath KK
Gastroenterology; 2007 Jun; 132(7):2412-21. PubMed ID: 17570215
[TBL] [Abstract][Full Text] [Related]
12. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
Menon S; Nightingale P; Trudgill N
J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
[TBL] [Abstract][Full Text] [Related]
13. Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a Pre-Barrett's esophagus setting.
Miyashita T; Shah FA; Marti G; Wang J; Armstrong T; Bonde P; Gibson MK; Yoshimura K; Montgomery EA; Duncan MD; Jaffee EM; Harmon JW
J Gastrointest Surg; 2008 Jan; 12(1):2-7; discussion 7-9. PubMed ID: 17957441
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
16. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma.
Li Y; Martin RC
Dis Esophagus; 2007; 20(5):372-8. PubMed ID: 17760649
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Barrett esophagus and esophageal adenocarcinoma by smoothened inhibitor in a rat model of gastroesophageal reflux disease.
Gibson MK; Zaidi AH; Davison JM; Sanz AF; Hough B; Komatsu Y; Kosovec JE; Bhatt A; Malhotra U; Foxwell T; Rotoloni CL; Hoppo T; Jobe BA
Ann Surg; 2013 Jul; 258(1):82-8. PubMed ID: 23108119
[TBL] [Abstract][Full Text] [Related]
18. Reflux esophagitis and carcinoma.
Ribet ME; Mensier EA
Surg Gynecol Obstet; 1992 Aug; 175(2):121-5. PubMed ID: 1636135
[TBL] [Abstract][Full Text] [Related]
19. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
20. Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model.
Kumagai H; Mukaisho K; Sugihara H; Bamba M; Miyashita T; Miwa K; Hattori T
Scand J Gastroenterol; 2003 Jul; 38(7):687-92. PubMed ID: 12889552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
